Life Sciences & Biotech · Primary channel: Organic Search
≥1,000 monthly visits, latest traffic breakdown per site.
71 products
Page 1 of 2 · Showing 1–50 of 71 products
≥1,000 monthly visits, latest traffic breakdown per site.
| Product | Tagline | Visits · Oct | MoM | Domain reg. | Revenue | Actions |
|---|---|---|---|---|---|---|
| 田 | Develops innovative medicines for people facing illness. | 393.4K | Up13.1% | 2025-02 | Undisclosed | |
| E | We are guided by the scientific spirit. Evident creates advanced life science and industrial microscopy solutions that help make the world… | 305.9K | Down15.6% | 2021-11 | Undisclosed | |
| R | Level Up with Canada’s Lab Tested Peptides | 173.5K | Down9.9% | 2025-07 | Undisclosed | |
| Н | Лабораторное и медицинское оборудование | 138.8K | Up6.1% | 2022-02 | Undisclosed | |
| N | Novonesis delivers strong first nine months and confirms full-year outlook | 123.6K | Down24.3% | 2023-09 | Undisclosed | |
| C | Scientific Equipment for Every Lab | 116.2K | Down0.2% | 2015-03 | $1.2M/yrClaimed | |
| R | Research peptides for sale, tested by independent labs. | 87.9K | Down13.8% | 2025-04 | Undisclosed | |
| F | FRAT® Detects **Blocking Autoantibodies Binding Autoantibodies** | 80.8K | Down11.8% | 2022-10 | Undisclosed | |
| S | Odczynniki chemiczne | 67.9K | Down9.0% | 2019-12 | Undisclosed | |
| P | Research supplier site listing peptide products for online selection. | 45.5K | Down2.9% | 2025-04 | Undisclosed | |
| V | Impurity reference standards & more | 42.6K | Down7.3% | — | Undisclosed | |
| S | One Site. Any Patient. Total Access. | 39.9K | Up51.3% | — | Undisclosed | |
| B | Transforming How The World Fights Cancer | 39.5K | Down6.9% | 2024-09 | Undisclosed | |
| P | ReSeARCH PePTIDeS YOU CAN TRUST | 39.1K | Down7.9% | 2024-11 | Undisclosed | |
| L | Every Lab Tool, one App | 36.1K | Up203% | 2026-01 | Undisclosed | |
| P | Canada’s Purest Peptides Every Batch Janoshik-Tested. | 35.8K | Down4.0% | 2026-03 | Undisclosed | |
| q | Scale-up from development to production. | 33.2K | Down16.4% | 1997-05 | Undisclosed | |
| A | Where patients meet research | 33.1K | Down27.1% | 2013-07 | Undisclosed | |
| B | We support research and educational institutions worldwide | 32.9K | Up22.5% | 2014-08 | Undisclosed | |
| P | Pure Bio Labs | High-Quality Research Peptides You Can Trust. | 25.1K | Down23.5% | 2024-02 | Undisclosed | |
| I | Iambic has created a cutting-edge AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient… | 25K | Down5.4% | 2023-02 | Undisclosed | |
| T | Eurofins Cosmetics Clinical Studies | 22.9K | Down29.8% | 2022-03 | Undisclosed | |
| M | The patient engagement engine for pharma portfolios | 22.1K | Down33.6% | — | Undisclosed | |
| Q | Open Software for Bioimage Analysis | 19.8K | Down30.8% | 2013-03 | Undisclosed | |
| A | Learn more about our 30-Year Anniversary → | 19.2K | Down1.8% | 2021-11 | Undisclosed | |
| B | Built to learn across every scale, from day one | 18.6K | Down20.6% | 2022-10 | Undisclosed | |
| T | Develops and supplies reliable medicines for patient care | 16.5K | Up11.1% | 2025-01 | Undisclosed | |
| A | ARTIFICIAL INTELLIGENCE TRANSFORMED ANALYSIS | 14.8K | Down10.4% | 2018-10 | Undisclosed | |
| P | The AI platform for biology. Analyze molecular data, run multi-omics workflows, and accelerate research — all in one workspace. | 13.5K | Prev <5K | 2024-08 | Undisclosed | |
| C | World leader in pharmaceutical excipients, vaccine adjuvants and lipid delivery systems for human and veterinary applications. | 12.8K | Down19.1% | 2022-02 | Undisclosed | |
| D | Premium Research Peptides | UK & EU Delivery – DN Research | 11.9K | Down57.7% | 2021-11 | Undisclosed | |
| R | Manage the research and business of clinical trials, together. | 11.8K | Down24.7% | 2024-02 | Undisclosed | |
| P | Buy Peptides Online from a USA Research Peptide Source | 10.8K | Up26.5% | 2024-02 | Undisclosed | |
| N | AI-native biotechnology company. Our mission is to leverage advanced machine learning methods to discover and develop cancer immunotherapies. | 10.4K | Down19.9% | 2022-06 | Undisclosed | |
| I | On a mission to rapidly and continually deliver antibody-based therapies that keep pace with the evolving viral threats | 10.3K | Down8.9% | 2022-08 | Undisclosed | |
| A | Your Reliable Partner in Drug Discovery! | 9.4K | Down32.5% | 2016-03 | Undisclosed | |
| S | Medicine is our platform. Accessibility is our cure. | 9.4K | Down9.7% | 2022-06 | Undisclosed | |
| A | Best-in-Class Therapies for Immunological and Inflammatory Diseases | 9.3K | Down11.3% | 2021-11 | Undisclosed | |
| S | Powerful experiments. AI-ready data. Ever faster discovery. | 8.8K | Up17.6% | — | Undisclosed | |
| 3 | GenAI + Bio | 8.5K | Down3.7% | 2020-06 | Undisclosed | |
| ア | Medicines and support for patients with serious rare diseases. | 8.4K | Down17.8% | 2024-04 | Undisclosed | |
| C | Adapting at The Speed of Science | 7.6K | Prev <5K | 2022-06 | Undisclosed | |
| O | Accelerate your microbiome research with One Codex | 7.6K | Down39.8% | 2014-07 | Undisclosed | |
| E | Transcend the LAB | 7.6K | Down8.4% | — | Undisclosed | |
| B | BioMed X – a leading innovation engine for pharma | 7.2K | Down14.7% | 2024-11 | Undisclosed | |
| C | R&D Updated information | 6.5K | Down13.6% | 2024-02 | Undisclosed | |
| K | UNPARALLELED LABORATORY ENVIRONMENTS | 6.2K | Down5.0% | — | Undisclosed | |
| H | Sparking Discovery, Elevating Humanity | 6.2K | Prev <5K | 2023-12 | Undisclosed | |
| R | Peptides Canada: Lab-Tested, Shipped from Ontario | 5.4K | Down52.0% | 2025-07 | Undisclosed | |
| T | Pure. Proven. Professional. | 5.3K | Down88.5% | — | Undisclosed |